Incontinence After Prostate Cancer Treatment: First Study to Identify Factors for Higher Risk

Incontinence After Prostate Cancer Treatment: First Study to Identify Factors for Higher Risk

ID: 160618

(firmenpresse) - TORONTO, ONTARIO -- (Marketwire) -- 06/27/12 -- Attention: Health and Lifestyle Editors

A man's likelihood of needing a urinary incontinence procedure doubles within a 15-year period after radical prostatectomy treatment for prostate cancer, with significant risk linked to increasing patient age, radiation after treatment and low surgeon volume, report Sunnybrook researchers in the first, large, long-term study of rates of incontinence procedures among over 25,000 Canadian men.

"We hope these findings will help patients and their physicians have a more informed discussion about the treatment decision and potential implications for long term impact on quality of life," says Dr. Robert Nam, lead investigator, urological oncologist, and head of the Genitourinary Cancer Care team at .

Published in the Journal of Urology, the study included 25,346 Canadian men who underwent radical prostatectomy for prostate cancer from 1993 to 2006. The researchers used hospital and cancer registry data to identify men who were later treated with surgical procedures for urinary incontinence.

Findings show the cumulative rate of post-prostatectomy incontinence surgery doubled from 2.8 percent at 5 years, to 4.8 percent at 15 years.

Factors predicting risk for incontinence surgery:

"Our findings also prompt much-needed dialogue among healthcare professionals about how we can further facilitate reduced complications for patients while continuing to have system resources to remedy in a timely manner, complications that do occur," says Dr. Nam, associate professor, Department of Surgery, , and associate scientist, Sunnybrook Research Institute.

Radical prostatectomy is a common treatment for clinically localized prostate cancer, or disease that has not spread beyond the prostate gland. Incontinence surgery involves the insertion of an artificial urinary sphincter or a urinary sling.

About 25,500 new cases of prostate cancer are diagnosed annually in Canada.







Contacts:
Sunnybrook
Natalie Chung-Sayers
416-480-4040

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  GlobeImmune's GI-4000 in Combination With Gemcitabine Following Surgery Shows Evidence of an Improvement in Survival in a Phase 2b Clinical Trial With Ras Mutation Positive Pancreas Cancer U.S. Food and Drug Administration Accepts Shionogi's Ospemifene New Drug Application in Vulvar and Vaginal Atrophy
Bereitgestellt von Benutzer: MARKETWIRE
Datum: 27.06.2012 - 15:30 Uhr
Sprache: Deutsch
News-ID 160618
Anzahl Zeichen: 0

contact information:
Town:

TORONTO, ONTARIO



Kategorie:

Hospitals, Facilities and Providers



Diese Pressemitteilung wurde bisher 400 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Incontinence After Prostate Cancer Treatment: First Study to Identify Factors for Higher Risk"
steht unter der journalistisch-redaktionellen Verantwortung von

Sunnybrook Health Sciences Centre (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Sunnybrook Health Sciences Centre



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
News zu Snacks finden Sie auf Snackeo.
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z